[Information provided by:
ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]
|NCT02367469 : Tryptophan Metabolism in Human Brain Tumors|
|Ages||Min: 13 Years Max: N/A|
1. Clinical and MRI diagnosis of an intracranial lesion suspicious for a brain tumor,
including primary and metastatic tumors, or a possible residual or recurrent brain
tumor (based on clinical imaging); or history of glioma treatment with chemoradiation,
even if no definite progression is found on clinical MRI.
2. Age ?13 years.
1. Severe increased intracranial pressure, status epilepticus, or other symptoms
requiring emergency or urgent intervention.
2. Resective surgery within 2 months prior to the PET scan (acute/subacute post-surgical
inflammatory changes may cause false positive increases on AMT PET).
3. Positive pregnancy test (because of radiation involved in PET scanning).
|Links||Permanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02367469
| Link to official Clinicaltrials.gov listing
Facility: Wayne State University
Csaba Juhasz, MD, PhD
Lynda Ferguson Phone: 313-993-0006
Click HERE to send email to this center